Microbial and fungal protease inhibitors - Current and potential applications

Applied Microbiology and Biotechnology

Volumn 93, Issue 4, 2012, Pages 1351-1375

  Sabotič, Jerica ^a   Kos, Janko ^a,b  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Crop protection; Disease; Fungi; Microorganisms; Protease; Protease inhibitor

Indexed keywords

ABIOTIC STRESS; BIOLOGICAL PROCESS; BIOTECHNOLOGICAL APPLICATIONS; CARDIO-VASCULAR DISEASE; CROP PROTECTION; FILAMENTOUS FUNGI; HETEROLOGOUS EXPRESSION; NEURODEGENERATIVE; PLANT PATHOGEN; POTENTIAL APPLICATIONS; PROTEASE; PROTEASE INHIBITOR; PROTEIN EXTRACTION; PROTEIN PURIFICATION; PROTEOLYTIC ACTIVITIES; PROTEOLYTIC ENZYME; REGULATORY FUNCTIONS; SMALL MOLECULES; THERAPEUTIC AGENTS; VERSATILE TOOLS;

AFFINITY CHROMATOGRAPHY; BIOTECHNOLOGY; CROPS; DIAGNOSIS; DISEASES; ENZYME ACTIVITY; FUNGI; MICROORGANISMS; NEURODEGENERATIVE DISEASES; PATHOGENS; PROTEINS; PROTEOLYSIS; PURIFICATION;

ENZYME INHIBITION;

ACIVICIN; ALPHA 2 MACROGLOBULIN; AMASTATIN; ANTIPAIN; APRIN; APROTININ; ASPERGILLUS ELASTASE INHIBITOR; CARBOXYPEPTIDASE Y INHIBITOR; CHAGASIN; CNISPIN; COSPIN; ECOTIN; LENTINUS PEPTIDASE INHIBITOR; MARINOSTATIN; MYCOCYPIN; OPRIN; OVOMUCOID; PEPTIDASE B INHIBITOR; PROTEIN AVR2; PROTEINASE; PROTEINASE INHIBITOR; SACCHAROPEPSIN INHIBITOR; SERINE PROTEINASE INHIBITOR; STAPHOSTATIN; STREPTOMYCES METALLOPEPTIDASE INHIBITOR; STREPTOMYCES SUBTILISIN INHIBITOR; STREPTOPAIN INHIBITOR; SURVIVIN; THYROPIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIOTECHNOLOGY; CANCER; CROP PRODUCTION; DISEASE TREATMENT; DROUGHT; ENZYME ACTIVITY; FUNGUS; GENE EXPRESSION; HERBIVORE; INHIBITOR; MOLECULAR ANALYSIS; PATHOGEN; PROTEOMICS; PURIFICATION;

AFFINITY CHROMATOGRAPHY; BACTERIAL INFECTION; BIOTECHNOLOGY; CROP PROTECTION; HETEROLOGOUS EXPRESSION; NEOPLASM; NONHUMAN; PARASITOSIS; PROTEIN DEGRADATION; PROTEIN PURIFICATION; SHORT SURVEY; VIRUS INFECTION;

AGRICULTURE; BACTERIA; BIOCHEMISTRY; FUNGI; MEDICINE; PROTEASE INHIBITORS;

BACTERIA (MICROORGANISMS); BASIDIOMYCOTA; FUNGI; PROKARYOTA;

EID: 84857912683     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-011-3834-x     Document Type: Short Survey

References (241)

1. Abbenante G, Fairlie DP (2005) Protease inhibitors in the clinic. Med Chem 1(1):71-104. doi:10.2174/1573406053402569
2. Adekoya OA, Sylte I (2009) The thermolysin family (M4) of enzymes: therapeutic and biotechnological potential. Chem Biol Drug Des 73(1):7-16. doi:10.1111/j.1747-0285.2008.00757.x
3. Akesson P, Moritz L, Truedsson M, Christensson B, von Pawel- Rammingen U (2006) IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection. Infect Immun 74(1):497-503. doi:10.1128/Iai.74.1.497-503.2006 (Pubitemid 43023105)
4. Akiyama Y (2009) Quality control of cytoplasmic membrane proteins in Escherichia coli. J Biochem 146(4):449-454. doi:10.1093/jb/mvp071
5. Allsop AE, Brooks G, Bruton G, Coulton S, Edwards PD, Hatton IK, Kaura AC, Mclean SD, Pearson ND, Smale TC, Southgate R (1995) Penem inhibitors of bacterial signal peptidase. Bioorg Med Chem Lett 5(5):443-448. doi:10.1016/0960-894X(95)00052-U
6. Amirhusin B, Shade RE, Koiwa H, Hasegawa PM, Bressan RA, Murdock LL, Zhu-Salzman K (2007) Protease inhibitors from several classes work synergistically against Callosobruchus maculatus. J Insect Physiol 53(7):734-740. doi:10.1016/j.jinsphys.2007.03.008 (Pubitemid 47069366)
7. Anderson J, Schiffer C, Lee SK, Swanstrom R (2009) Viral protease inhibitors. Handb Exp Pharmacol 189:85-110. doi:10.1007/978-3-540-79086-0-4
8. Armstrong PB, Quigley JP (1999) Alpha2-macroglobulin: an evolutionarily conserved arm of the innate immune system. Dev Comp Immunol 23(4-5):375-390 (Pubitemid 29309614)
9. Ascenzi P, Bocedi A, Bolognesi M, Spallarossa A, Coletta M, De Cristofaro R, Menegatti E (2003) The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein. Curr Protein Pept Sci 4(3):231-251. doi:10.2174/1389203033487180 (Pubitemid 36656736)
10. Avanzo P, Sabotič J, Anžlovar S, Popovič T, Leonardi A, Pain RH, Kos J, Brzin J (2009) Trypsin-specific inhibitors from the basidiomycete Clitocybe nebularis with regulatory and defensive functions.Microbiology 155(Pt 12):3971-3981. doi:10.1099/mic.0.032805-0
11. Bachovchin WW, Plaut AG, Flentke GR, Lynch M, Kettner CA (1990) Inhibition of IgA1 proteinases from Neisseria gonorrhoeae and Hemophilus influenzae by peptide prolyl boronic acids. J Biol Chem 265(7):3738-3743
12. Banbula A, Mak P, Bugno M, Silberring J, Dubin A, Nelson D, Travis J, Potempa J (1999) Prolyl tripeptidyl peptidase from Porphyromonas gingivalis. A novel enzyme with possible pathological implications for the development of periodontitis. J Biol Chem 274(14):9246-9252. doi:10.1074/jbc.274.14.9246
13. Barequet IS, Habot-Wilner Z, Mann O, Safrin M, Ohman DE, Kessler E, Rosner M (2009) Evaluation of Pseudomonas aeruginosa staphylolysin (LasA protease) in the treatment of methicillin-resistant Staphylococcus aureus endophthalmitis in a rat model. Graefes Arch Clin Exp Ophthalmol 247(7):913-917. doi:10.1007/s00417-009-1061-2
14. Barla F, Higashijima H, Funai S, Sugimoto K, Harada N, Yamaji R, Fujita T, Nakano Y, Inui H (2009) Inhibitive effects of alkyl gallates on hyaluronidase and collagenase. Biosci Biotechnol Biochem 73(10):2335-2337
15. Barrett AJ (2001) Proteolytic enzymes: nomenclature and classification. In: Beynon RJ, Bond JS (eds) Proteolytic enzymes: a practical approach, 2nd edn. Oxford University Press, Oxford, pp 1-21
16. Barrett AJ, Rawlings ND, Woessner JF (2004) Handbook of proteolytic enzymes, 2nd edn. Academic Press, London
17. Barrios V, Escobar C (2010) Aliskiren in the management of hypertension. Am J Cardiovasc Drugs 10(6):349-358. doi:10.2165/11584980-000000000-00000
18. Beaulieu C, Isabel E, Fortier A, Masse F, Mellon C, Methot N, Ndao M, Nicoll-Griffith D, Lee D, Park H, BlackWC (2010) Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease. Bioorg Med Chem Lett 20(24):7444-7449. doi:10.1016/j.bmcl.2010.10.015
19. Behnsen J, Lessing F, Schindler S,Wartenberg D, Jacobsen ID, Thoen M, Zipfel PF, Brakhage AA (2010) Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5. Infect Immun 78(8):3585-3594. doi:10.1128/IAI.01353-09
20. Benchabane M, Goulet C, Rivard D, Faye L, Gomord V, Michaud D (2008) Preventing unintended proteolysis in plant protein biofactories. Plant Biotechnol J 6(7):633-648. doi:10.1111/j.1467-7652.2008.00344.x
21. Benchabane M, Schluter U, Vorster J, Goulet MC, Michaud D (2010) Plant cystatins. Biochimie 92(11):1657-1666. doi:10.1016/j.biochi.2010.06.006
22. Benes P, Vetvicka V, Fusek M (2008) Cathepsin D - many functions of one aspartic protease. Crit Rev Oncol Hematol 68(1):12-28. doi:10.1016/j.critrevonc. 2008.02.008
23. Berggren K, Johansson B, Fex T,Kihlberg J, Bjorck L, Luthman K(2009) Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant. Bioorg Med Chem 17(9):3463-3470. doi:10.1016/j.bmc.2009.03.026
24. Bialas A, Kafarski P (2009) Proteases as anti-cancer targets - molecular and biological basis for development of inhibitor-like drugs against cancer. Anticancer Agents Med Chem 9(7):728-762
25. Bien CM, Chang YC, Nes WD, Kwon-Chung KJ, Espenshade PJ (2009) Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs.MolMicrobiol 74(3):672-690. doi:10.1111/j.1365- 2958.2009.06895.x
26. Blommaert A, Turcaud S, Anne C, Roques BP (2004) Small tripeptide surrogates with low nanomolar affinity as potent inhibitors of the botulinum neurotoxin B metallo-proteolytic activity. Bioorg Med Chem 12(11):3055-3062. doi:10.1016/j.bmc.2004.03.006 (Pubitemid 38622139)
27. Boekhout T, Gueidan C, de Hoog S, Samson R, Varga J, Walther G (2009) Fungal taxonomy: new developments in medically important fungi. Curr Fung Infect Rep 3(3):170-178. doi:10.1007/s12281-009-0022-x
28. Bolter CJ, LatoszekGreen M (1997) Effect of chronic ingestion of the cysteine proteinase inhibitor, E-64, on Colorado potato beetle gut proteinases. Entomol Exp Appl 83(3):295-303. doi:10.1046/j.1570-7458.1997.00184.x
29. Bonade-BottinoM, Lerin J, Zaccomer B, Jouanin L (1999) Physiological adaptation explains the insensitivity of Baris coerulescens to transgenic oilseed rape expressing oryzacystatin I. Insect BiochemMolec 29(2):131-138. doi:10.1016/S0965-1748(98)00116-7 (Pubitemid 29149074)
30. Braga-Silva LA, Santos AL (2011) Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis. Curr Med Chem 18(16):2401-2419
31. Brak K, Kerr ID, Barrett KT, Fuchi N, Debnath M, Ang K, Engel JC, McKerrow JH, Doyle PS, Brinen LS, Ellman JA (2010) Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy. J Med Chem 53(4):1763-1773. doi:10.1021/jm901633v
32. Bray EA (1993) Molecular responses to water deficit. Plant Physiol 103(4):1035-1040. doi:103/4/1035
33. Bromme D, Lecaille F (2009) Cathepsin K inhibitors for osteoporosis and potential off-target effects. Expert Opin Investig Drugs 18 (5):585-600. doi:10.1517/13543780902832661
34. Brzin J, Kidrič M (1995) Proteinases and their inhibitors in plants: role in normal growth and in response to various stress conditions. Biotechnol Genet Eng Rev 13:420-467
35. Brzin J, Rogelj B, Popovič T, Štrukelj B, Ritonja A (2000) Clitocypin, a new type of cysteine proteinase inhibitor from fruit bodies of mushroom Clitocybe nebularis. J Biol Chem 275(26):20104-20109. doi:10.1074/jbc.M001392200 (Pubitemid 30441621)
36. Burton J, Wood SG, Lynch M, Plaut AG (1988) Substrate analogue inhibitors of the IgA1 proteinases from Neisseria gonorrhoeae. J Med Chem 31(8):1647-1651. doi:10.1021/jm00403a027
37. Buzder-Lantos P, Bockstael K, Anne J, Herdewijn P (2009) Substrate based peptide aldehyde inhibits bacterial type I signal peptidase. Bioorg Med Chem Lett 19(10):2880-2883. doi:10.1016/j.bmcl.2009.03.064
38. Carrillo L, Martinez M, Ramessar K, Cambra I, Castanera P, Ortego F, Diaz I (2011) Expression of a barley cystatin gene in maize enhances resistance against phytophagous mites by altering their cysteine-proteases. Plant Cell Rep 30(1):101-112. doi:10.1007/s00299-010-0948-z
39. Cecarini V, Cuccioloni M, Mozzicafreddo M, Bonfili L, Angeletti M, ME A (2011) Targeting proteasomes with natural occurring compounds in cancer treatment. Curr Cancer Drug Targets 11(3):307-324. doi:10.2174/ 156800911794519815
40. Chen D, Frezza M, Schmitt S, Kanwar J, PD Q (2011) Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives. Curr Cancer Drug Targets 11(3):239-253. doi:10.2174/ 156800911794519752
41. Cheng Q, Stafslien D, Purushothaman SS, Cleary P (2002) The group B streptococcal C5a peptidase is both a specific protease and an invasin. Infect Immun 70(5):2408-2413. doi:10.1128/IAI.70.5.2408-2413.2002 (Pubitemid 34408382)
42. Christeller JT (2005) Evolutionary mechanisms acting on proteinase inhibitor variability. FEBS J 272(22):5710-5722. doi:10.1111/j.1742-4658.2005. 04975.x
43. Christou P, Capell T, Kohli A, Gatehouse JA, Gatehouse AM (2006) Recent developments and future prospects in insect pest control in transgenic crops. Trends Plant Sci 11(6):302-308. doi:10.1016/j.tplants.2006.04.001 (Pubitemid 43884900)
44. Clancy KW, Melvin JA, McCafferty DG (2010) Sortase transpeptidases: insights into mechanism, substrate specificity, and inhibition. Biopolymers 94(4):385-396. doi:10.1002/bip. 21472
45. Collin M, Olsen A (2003) Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes. Infect Immun 71(6):2983-2992. doi:10.1128/IAI.71.6.2983-2992.2003 (Pubitemid 36637518)
46. Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295 (5564):2387-2392. doi:10.1126/science.1067100 (Pubitemid 34270240)
47. Cronan CA, Potempa J, Travis J, Mayo JA (2006) Inhibition of Porphyromonas gingivalis proteinases (gingipains) by chlorhexidine: synergistic effect of Zn(II). Oral Microbiol Immunol 21 (4):212-217. doi:10.1111/j.1399- 302X.2006.00277.x (Pubitemid 44336950)
48. Crowder MW (2006) Combating vancomycin resistance in bacteria: targeting the D-ala-D-ala dipeptidase VanX. Infect Disord Drug Targets 6(2):147-158. doi:10.2174/187152606784112146
49. Curtis MA, Aduse Opoku J, Rangarajan M, Gallagher A, Sterne JA, Reid CR, Evans HE, Samuelsson B (2002) Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic Kgp protease inhibitor. Infect Immun 70(12):6968-6975. doi:10.1128/IAI.70.12.6968-6975.2002 (Pubitemid 35387932)
50. Dash C, Rao M (2001) Interactions of a novel inhibitor from an extremophilic Bacillus sp. with HIV-1 protease: implications for the mechanism of inactivation. J Biol Chem 276(4):2487-2493. doi:10.1074/jbc.M005662200
51. Dash C, Kulkarni A, Dunn B, Rao M (2003) Aspartic peptidase inhibitors: implications in drug development. Crit Rev Biochem Mol Biol 38(2):89-119. doi:10.1080/713609213 (Pubitemid 36571002)
52. De Strooper B, Vassar R, Golde T (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 6 (2):99-107. doi:10.1038/nrneurol.2009.218
53. Dekker N, Cox RC, Kramer RA, Egmond MR (2001) Substrate specificity of the integral membrane protease OmpT determined by spatially addressed peptide libraries. Biochemistry 40(6):1694-1701. doi:10.1021/bi0014195 (Pubitemid 32144039)
54. Desai PN, Shrivastava N, Padh H (2010) Production of heterologous proteins in plants: strategies for optimal expression. Biotechnol Adv 28(4):427-435. doi:10.1016/j.biotechadv.2010.01.005
55. Desbois AP, Coote PJ (2011) Bactericidal synergy of lysostaphin in combination with antimicrobial peptides. Eur J Clin Microbiol Infect Dis 30(8):1015-1021. doi:10.1007/s10096-011-1188-z
56. Dohmae N, Takio K, Tsumuraya Y, Hashimoto Y (1995) The complete amino acid sequences of two serine proteinase inhibitors from the fruiting bodies of a basidiomycete, Pleurotus ostreatus. Arch Biochem Biophys 316(1):498-506. doi:10.1006/abbi.1995.1066
57. Doran PM (2006) Foreign protein degradation and instability in plants and plant tissue cultures. Trends Biotechnol 24(9):426-432. doi:10.1016/j.tibtech. 2006.06.012
58. Dorman G, Cseh S, Hajdu I, Barna L, Konya D, Kupai K, Kovacs L, Ferdinandy P (2010) Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.Drugs 70(8):949-964. doi:10.2165/11318390-000000000-00000
59. Drag M, Salvesen GS (2010) Emerging principles in protease-based drug discovery. Nat Rev Drug Discov 9(9):690-701. doi:10.1038/nrd3053
60. Dubin G (2003) Defense against own arms: staphylococcal cysteine proteases and their inhibitors. Acta Biochim Pol 50(3):715-724
61. Dubin G, Wladyka B, Stec-Niemczyk J, Chmiel D, Zdzalik M, Dubin A, Potempa J (2007) The staphostatin family of cysteine protease inhibitors in the genus Staphylococcus as an example of parallel evolution of protease and inhibitor specificity. Biol Chem 388 (2):227-235. doi:10.1515/BC.2007.025 (Pubitemid 46184152)
62. Duche D, Issouf M, Lloubes R (2009) Immunity protein protects colicin E2 from OmpT protease. J Biochem 145(1):95-101. doi:10.1093/jb/mvn149
63. Dunaevsky YE, Elpidina EN, Vinokurov KS, Belozersky MA (2005) Protease inhibitors: use to increase plant tolerance to insects and pathogens. Mol Biol 39(4):702-708
64. Duschak VG, Couto AS (2009) Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. Curr Med Chem 16(24):3174-3202. doi:10.2174/092986709788802971
65. Eggers CT,Wang SX, Fletterick RJ, Craik CS (2001) The role of ecotin dimerization in protease inhibition. J Mol Biol 308(5):975-991. doi:10.1006/jmbi.2001.4754 (Pubitemid 32574373)
66. Ersmark K, Samuelsson B, Hallberg A (2006) Plasmepsins as potential targets for new antimalarial therapy. Med Res Rev 26(5):626-666. doi:10.1002/med.20082 (Pubitemid 44230415)
67. Eschenlauer SC, Faria MS, Morrison LS, Bland N, Ribeiro-Gomes FL, DosReis GA, Coombs GH, Lima AP, Mottram JC (2009) Influence of parasite encoded inhibitors of serine peptidases in early infection of macrophages with Leishmania major. Cell Microbiol 11(1):106-120. doi:10.1111/j.1462-5822.2008. 01243.x
68. Feller U (2004) Proteolysis. In: Larry DN (ed) Plant cell death processes. Academic Press, San Diego, pp 107-123
69. Ferry N, Gatehouse AMR (2010) In: Kole C, Michler CH, Abbott AG, Hall TC (eds) Transgenic crop plants for resistance to biotic stress. Springer Berlin, Heidelberg, pp 1-65. doi:10.1007/978-3-642-04812-8-1
70. Fitzpatrick RE, Wijeyewickrema LC, Pike RN (2009) The gingipains: scissors and glue of the periodontal pathogen, Porphyromonas gingivalis. Future Microbiol 4(4):471-487. doi:10.2217/fmb.09.18
71. Frlan R, Gobec S (2006) Inhibitors of cathepsin B. Curr Med Chem 13 (19):2309-2327. doi:10.2174/092986706777935122 (Pubitemid 44184655)
72. Fukushima K, Arai M, Kohno Y, Suwa T, Satoh T (1990) An epoxysuccinic acid derivative(loxistatin)-induced hepatic injury in rats and hamsters. Toxicol Appl Pharmacol 105(1):1-12. doi:10.1016/0041-008X(90)90353-V
73. GE (2007) Affinity chromatography: principles and methods. GE Healthcare Bio-Sciences AB, Uppsala
74. Gil LA, Valiente PA, Pascutti PG, Pons T (2011) Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design. J Trop Med 2011:657483. doi:10.1155/2011/657483
75. Green TB, Ganesh O, Perry K, Smith L, Phylip LH, Logan TM, Hagen SJ, Dunn BM, Edison AS (2004) IA3, an aspartic proteinase inhibitor from Saccharomyces cerevisiae, is intrinsically unstructured in solution. Biochemistry 43(14):4071-4081. doi:10.1021/bi034823n (Pubitemid 38445626)
76. Greenbaum LM, Sutherland JH (1983) Host cathepsin D response to tumor in the normal and pepstatin-treated mouse. Cancer Res 43 (6):2584-2587. doi:0008-5472/83/0043-0000
77. Hanada K, Tamai M, Yamagishi M, Ohmura S, Sawada J, Tanaka I (1978) Isolation and characterization of E-64, a new thiol protease inhibitor. Agr Biol Chem Tokyo 42(3):523-528. doi:10.1271/bbb1961.42.523 (Pubitemid 8343851)
78. Haq SK, Atif SM, Khan RH (2004) Protein proteinase inhibitor genes in combat against insects, pests, and pathogens: natural and engineered phytoprotection. Arch Biochem Biophys 431(1):145-159. doi:10.1016/j.abb.2004.07. 022 (Pubitemid 39349368)
79. Haq SK, Rabbani G, Ahmad E, Atif SM, Khan RH (2010) Protease inhibitors: a panacea? J Biochem Mol Toxicol 24(4):270-277. doi:10.1002/jbt.20335
80. Harris DA, Powers ME, Romesberg FE (2009) Synthesis and biological evaluation of penem inhibitors of bacterial signal peptidase. Bioorg Med Chem Lett 19(14):3787-3790. doi:10.1016/j.bmcl.2009.04.034
81. Hoekstra FA, Golovina EA, Buitink J (2001) Mechanisms of plant desiccation tolerance. Trends Plant Sci 6(9):431-438. doi:10.1016/s1360-1385(01) 02052-0
82. Holz RC, Bzymek KP, Swierczek SI (2003) Co-catalytic metallopeptidases as pharmaceutical targets. Curr Opin Chem Biol 7(2):197-206. doi:10.1016/S1367- 5931(03)00033-4 (Pubitemid 36514951)
83. Hook V, Kindy M, Hook G (2007) Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease. Biol Chem 388(2):247-252. doi:10.1515/BC.2007.027 (Pubitemid 46184154)
84. Hozumi M, Ogawa M, Sugimura T, Takeuchi T, Umezawa H (1972) Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from actinomycetes. Cancer Res 32(8):1725-1728
85. Hritonenko V, Stathopoulos C (2007) Omptin proteins: an expanding family of outer membrane proteases in Gram-negative Enterobacteriaceae. Mol Membr Biol 24(5-6):395-406. doi:10.1080/09687680701443822 (Pubitemid 47290682)
86. Huang HK, Bailis JM, Leverson JD, Gomez EB, Forsburg SL, Hunter T (2005) Suppressors of Bir1p (survivin) identify roles for the chromosomal passenger protein Pic1p (INCENP) and the replication initiation factor Psf2p in chromosome segregation. Mol Cell Biol 25(20):9000-9015. doi:10.1128/MCB.25.20.9000-9015. 2005 (Pubitemid 41429089)
87. Huang YM, Xiao BZ, Xiong LZ (2007) Characterization of a stress responsive proteinase inhibitor gene with positive effect in improving drought resistance in rice. Planta 226(1):73-85. doi:10.1007/s00425-006-0469-8
88. Igarashi Y, Heureux E, DoctorKS, Talwar P, Gramatikova S,Gramatikoff K, Zhang Y, Blinov M, Ibragimova SS, Boyd S, Ratnikov B, Cieplak P, Godzik A, Smith JW, Osterman AL, Eroshkin AM (2009) PMAP: databases for analyzing proteolytic events and pathways. Nucleic Acids Res 37(Database issue):D611-D618. doi:10.1093/nar/gkn683
89. Imamura T, Matsushita K, Travis J, Potempa J (2001) Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues. Antimicrob Agents Chemother 45(10):2871-2876. doi:10.1128/AAC.45.10.2871-2876.2001 (Pubitemid 32906685)
90. Istinič I, Buh Gašparič M, Sabotič J, Gruden K, Brzin J, Žel J (2011) Uporaba makrocipinov kot pesticidnih učinkovin. SI P-201100304
91. Jacobsen FE, Lewis JA, Cohen SM (2007) The design of inhibitors for medicinally relevant metalloproteins. ChemMedChem 2(2):152-171. doi:10.1002/cmdc.200600204
92. Jevnikar Z, Obermajer N, Bogyo M, Kos J (2008) The role of cathepsin X in the migration and invasiveness of T lymphocytes. J Cell Sci 121(Pt 16):2652-2661. doi:10.1242/jcs.023721
93. Johansson N, Ahonen M, Kahari VM (2000) Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 57(1):5-15. doi:10.1007/s000180050495 (Pubitemid 30105326)
94. Johnson SL, Chen LH, Barile E, Emdadi A, Sabet M, Yuan H, Wei J, Guiney D, Pellecchia M (2009) Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors. Bioorg Med Chem 17(9):3352-3368. doi:10.1016/j.bmc.2009.03.040
95. Jongsma MA, Beekwilder J (2008) Plant protease inhibitors: functional evolution for defense. In: Schaller A (ed) Induced plant resistance to herbivory. Springer, Netherlands, pp 235-251. doi:10.1007/978-1-4020-8182-8-11
96. Jozwiak J, Komar A, Jankowska E, Martirosian G (2005) Determination of the cytotoxic effect of Clostridium histolyticum culture supernatant on HeLa cells in the presence of protease inhibitors. FEMS Immunol Med Microbiol 45(2):137-142. doi:10.1016/j.femsim.2005.03.005 (Pubitemid 41039997)
97. Kadowaki T, Baba A, Abe N, Takii R, Hashimoto M, Tsukuba T, Okazaki S, Suda Y, Asao T, Yamamoto K (2004) Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors. Mol Pharmacol 66(6):1599-1606. doi:10.1124/mol.104.004366 (Pubitemid 39564787)
98. Kagawa TF, O'Toole PW, Cooney JC (2005) SpeB-Spi: a novel protease-inhibitor pair from Streptococcus pyogenes.MolMicrobiol 57(3):650-666. doi:10.1111/j.1365-2958.2005.04708.x (Pubitemid 41025949)
99. Kanaori K, Kamei K, Taniguchi M, Koyama T, Yasui T, Takano R, Imada C, Tajima K, Hara S (2005) Solution structure of marinostatin, a natural ester-linked protein protease inhibitor. Biochemistry 44 (7):2462-2468. doi:10.1021/bi048034x (Pubitemid 40279549)
100. Kantyka T, Rawlings ND, Potempa J (2010) Prokaryote-derived protein inhibitors of peptidases: a sketchy occurrence and mostly unknown function. Biochimie. doi:10.1016/j.biochi.2010.06.004
101. Kaspari M, Bogner E (2009) Antiviral activity of proteasome inhibitors/ cytomegalovirus. In: Lendeckel U, Hooper NM (eds) Viral proteases and antiviral protease inhibitor therapy. Springer Media B.V, Houten, pp 71-81
102. Katunuma N (1997) New aspects on antigen presentation mechanism for immune-responses and allergy expression. In: Katunuma N, Fritz H, Kido H, Travis J (eds) Medical aspects of proteases and protease inhibitors. IOS Press, Tokyo: Ohmsha, Amsterdam, pp 153-163
103. Katunuma N (2011) Structure-based development of specific inhibitors for individual cathepsins and their medical applications. Proc Jpn Acad Ser B Phys Biol Sci 87(2):29-39. doi:10.2183/pjab.87.29
104. Kidrič M, Fabian H, Brzin J, Popovič T, Pain RH (2002) Folding, stability, and secondary structure of a new dimeric cysteine proteinase inhibitor. Biochem Biophys Res Commun 297(4):962-967. doi:10.1016/S0006- 291X(02)02328-8
105. Kim JH, Mullin CA (2003) Antifeedant effects of proteinase inhibitors on feeding behaviors of adult western corn rootworm (Diabrotica virgifera virgifera). J Chem Ecol 29(4):795-810. doi:10.1023/A:1022919413625 (Pubitemid 36438257)
106. Kim J, Yoon MY (2006) Anthrax lethal factor: Critical virulence factor of pathogenesis of anthrax toxins. Toxin Rev 25(1):109-124. doi:10.1080/ 15569540500320987 (Pubitemid 43254545)
107. Kim J, Park HC, Gedi V, Park HY, Roberts AG, Atkins WM, Yoon MY (2011) Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors. Biochem Bioph Res Co 404(1):517-522. doi:10.1016/j.bbrc.2010. 12.015
108. Kisselev AF, Goldberg AL (2001) Proteasome inhibitors: from research tools to drug candidates. Chem Biol 8(8):739-758. doi:10.1016/S1074-5521(01) 00056-4 (Pubitemid 32752454)
109. Knox DP (2007) Proteinase inhibitors and helminth parasite infection. Parasite Immunol 29(2):57-71. doi:10.1111/j.1365-3024.2006.00913.x
110. Kobiler O, Rokney A, Oppenheim AB (2007) Phage lambda CIII: a protease inhibitor regulating the lysis-lysogeny decision. PLoS One 2(4):e363. doi:10.1371/journal.pone.0000363
111. Kojima S, Minagawa T, Miura K (1997) The propeptide of subtilisin BPN' as a temporary inhibitor and effect of an amino acid replacement on its inhibitory activity. FEBS Lett 411(1):128-132. doi:10.1016/S0014-5793(97)00678-9 (Pubitemid 27298386)
112. Kojima S, Deguchi M, Miura K (1999) Involvement of the C-terminal region of yeast proteinase B inhibitor 2 in its inhibitory action. J Mol Biol 286(3):775-785. doi:10.1006/jmbi.1998.2498 (Pubitemid 29106217)
113. Kojima S, Iwahara A, Yanai H (2005) Inhibitor-assisted refolding of protease: a protease inhibitor as an intramolecular chaperone. FEBS Lett 579(20):4430-4436. doi:10.1016/j.febslet.2005.06.083 (Pubitemid 41116377)
114. Kos J, Lah TT (1998) Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep 5(6):1349-1361 (Pubitemid 28474074)
115. Kumar CG, Takagi H (1999) Microbial alkaline proteases: from a bioindustrial viewpoint. Biotechnol Adv 17(7):561-594. doi:10.1016/S0734- 9750(99)00027-0 (Pubitemid 30086544)
116. Kumar S, Chandra A, Pandey KC (2008) Bacillus thuringiensis (Bt) transgenic crop: an environment friendly insect-pest management strategy. J Environ Biol 29(5):641-653
117. Kunkel B, Chen Z (2006) Virulence strategies of plant pathogenic bacteria. In: Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E (eds) The Prokaryotes. Springer, New York, pp 421-440. doi:10.1007/0-387-30742- 7-14
118. Ladhani S (2003) Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. FEMS Immunol Med Microbiol 39(2):181-189. doi:10.1016/S0928-8244(03)00225-6
119. Lah TT, Duran Alonso MB, Van Noorden CJ (2006) Antiprotease therapy in cancer: hot or not? Expert Opin Biol Ther 6(3):257-279. doi:10.1517/14712598.6. 3.257 (Pubitemid 43344745)
120. Lange CM, Sarrazin C, Zeuzem S (2010) Review article: specifically targeted anti-viral therapy for hepatitis C-a new era in therapy. Aliment Pharmacol Ther 32(1):14-28. doi:10.1111/j.1365-2036.2010.04317.x
121. Lara P, Ortego F, Gonzalez-Hidalgo E, Castanera P, Carbonero P, Diaz I (2000) Adaptation of Spodoptera exigua (Lepidoptera: Noctuidae) to barley trypsin inhibitor BTI-CMe expressed in transgenic tobacco. Transgenic Res 9(3):169-178. doi:10.1023/A:1008905631440
122. Law RH, Zhang Q, McGowan S, Buckle AM, Silverman GA, Wong W, Rosado CJ, Langendorf CG, Pike RN, Bird PI, Whisstock JC (2006) An overview of the serpin superfamily. Genome Biol 7 (5):216. doi:10.1186/gb-2006-7-5-216
123. Li F, Terzyan S, Tang J (2011) Subsite specificity of anthrax lethal factor and its implications for inhibitor development. Biochem Biophys Res Commun 407(2):400-405. doi:10.1016/j.bbrc.2011.03.033
124. Lopez-Otin C, Bond JS (2008) Proteases: multifunctional enzymes in life and disease. J Biol Chem 283(45):30433-30437. doi:10.1074/jbc.R800035200
125. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339 (8):520-532. doi:10.1056/NEJM199808203390806
126. Luthringer B, Isbert S, Muller WE, Zilberberg C, Thakur NL, Worheide G, Stauber RH, Kelve M, Wiens M (2010) Poriferan survivin exhibits a conserved regulatory role in the interconnected pathways of cell cycle and apoptosis. Cell Death Differ. doi:10.1038/cdd.2010.87
127. Maeda H (1996) Role of microbial proteases in pathogenesis. Microbiol Immunol 40(10):685-699
128. Malone LA, Gatehouse AMR, Barratt BIP (2008) Beyond Bt: alternative strategies for insect-resistant genetically modified crops. In: Romeis J, Shelton AM, Kennedy GG (eds) Integration of insectresistant genetically modified crops within IPM programs, vol 5. Progress in biological control. Springer, Netherlands, pp 357-417. doi:10.1007/978-1-4020-8373-0-13
129. Manabe S, Nariya H, Miyata S, Tanaka H, Minami J, Suzuki M, Taniguchi Y, Okabe A (2010) Purification and characterization of a clostripainlike protease from a recombinant Clostridium perfringens culture. Microbiology 156(Pt 2):561-569. doi:10.1099/mic.0.031609-0
130. Maresso AW, Schneewind O (2008) Sortase as a target of antiinfective therapy. Pharmacol Rev 60(1):128-141. doi:10.1124/pr.107.07110
131. Marie C, White TC (2009) Genetic basis of antifungal drug resistance. Curr Fungal Infect Rep 3(3):163-169. doi:10.1007/s12281-009-0021-y
132. McCarter J (2009) Molecular approaches toward resistance to plantparasitic nematodes. In: Berg R, Taylor C (eds) Cell biology of plant nematode parasitism, vol 15. Plant Cell Monographs. Springer Berlin, Heidelberg, pp 239-267. doi:10.1007/978-3-540-85215-5-9
133. McGavin MJ, Zahradka C, Rice K, Scott JE (1997) Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease. Infect Immun 65(7):2621-2628. doi:PMC175371
134. McKerrow JH, Rosenthal PJ, Swenerton R, Doyle P (2008) Development of protease inhibitors for protozoan infections. Curr Opin Infect Dis 21(6):668-672. doi:10.1097/QCO.0b013e328315cca9
135. McKerrow JH, Doyle PS, Engel JC, Podust LM, Robertson SA, Ferreira R, Saxton T, Arkin M, Kerr ID, Brinen LS, Craik CS (2009) Two approaches to discovering and developing new drugs for Chagas disease. Mem Inst Oswaldo Cruz 104(Suppl 1):263-269. doi:10.1590/S0074-02762009000900034
136. C in complex with the cognate proteinase reveals a novel mode of the proteinase-protein inhibitor interaction. J Mol Biol 346 (5):1323-1334. doi:10.1016/j.jmb.2004.12.051
137. Mima J, Fukada H, Nagayama M, Ueda M (2006) Specific membrane binding of the carboxypeptidase Y inhibitor I(C), a phosphatidylethanolamine-binding protein family member. FEBS J 273(23):5374-5383. doi:10.1111/j.1742-4658.2006. 05530.x (Pubitemid 44772394)
138. Mistry D, Stockley RA (2006) IgA1 protease. Int J Biochem Cell Biol 38(8):1244-1248. doi:10.1016/j.biocel.2005.10.005
139. Miyoshi S, Shinoda S (2000) Microbial metalloproteases and pathogenesis. Microbes Infect 2(1):91-98. doi:10.1016/S1286-4579(00)00280-X (Pubitemid 30077931)
140. Monod M (2008) Secreted proteases from dermatophytes. Mycopathologia 166(5-6):285-294. doi:10.1007/s11046-008-9105-4
141. Mosolov VV, Valueva TA (2006) Participation of proteolytic enzymes in the interaction of plants with phytopathogenic microorganisms. Biochem Mosc 71(8):838-845. doi:10.1134/S0006297906080037 (Pubitemid 44273659)
142. Mucha A, Drag M, Dalton JP, Kafarski P (2010) Metalloaminopeptidase inhibitors. Biochimie 92(11):1509-1529. doi:10.1016/j.biochi.2010.04.026
143. Naglik JR, Challacombe SJ, Hube B (2003) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67(3):400-428. doi:10.1128/MMBR.67.3.400-428.2003 (Pubitemid 37122527)
144. Naglik J, Albrecht A, Bader O, Hube B (2004) Candida albicans proteinases and host/pathogen interactions. Cell Microbiol 6 (10):915-926. doi:10.1111/j.1462-5822.2004.00439.x (Pubitemid 39255605)
145. Neubauer D, Steinberger J, Skern T (2009) Picornaviruses. In: Lendeckel U, Hooper NM (eds) Viral proteases and antiviral protease inhibitor therapy. Springer Media B.V, Houten, pp 101-130
146. Nguyen JT, Hamada Y, Kimura T, Kiso Y (2008) Design of potent aspartic protease inhibitors to treat various diseases. Arch Pharm (Weinheim) 341(9):523-535. doi:10.1002/ardp. 200700267
147. Obermajer N, Doljak B, Jamnik P, Fonovic UP, Kos J (2009) Cathepsin X cleaves the C-terminal dipeptide of alpha- and gammaenolase and impairs survival and neuritogenesis of neuronal cells. Int J Biochem Cell Biol 41(8-9):1685-1696. doi:10.1016/j.biocel.2009.02.019
148. Odani S, Tominaga K, Kondou S, Hori H, Koide T, Hara S, Isemura M, Tsunasawa S (1999) The inhibitory properties and primary structure of a novel serine proteinase inhibitor from the fruiting body of the basidiomycete, Lentinus edodes. Eur J Biochem 262 (3):915-923. doi:10.1046/j.1432-1327.1999. 00463.x (Pubitemid 29291052)
149. Okumura Y, Ogawa K, Uchiya K, Nikai T (2006) Isolation and characterization of a novel elastase inhibitor, AFLEI from Aspergillus flavus. Nippon Ishinkin Gakkai Zasshi 47(3):219-224. doi:10.3314/jjmm.47.219 (Pubitemid 44357809)
150. Okumura Y, Matsui T, Ogawa K, Uchiya K, Nikai T (2008) Biochemical properties and primary structure of elastase inhibitor AFUEI from Aspergillus fumigatus. J Med Microbiol 57(Pt 7):803-808. doi:10.1099/jmm.0.47789-0
151. Olivier M, Hassani K (2010) Protease inhibitors as prophylaxis against leishmaniasis: new hope from the major surface protease gp63. Future Med Chem 2(4):539-542. doi:10.4155/fmc.10.17
152. OndettiMA, Rubin B, Cushman DW(1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196(4288):441-444. doi:10.1126/science.191908 (Pubitemid 8073845)
153. Oppert B, Morgan TD, Kramer KJ (2011) Efficacy of Bacillus thuringiensis Cry3Aa protoxin and protease inhibitors against coleopteran storage pests. Pest Manag Sci 67(5):568-573. doi:10.1002/ps.2099
154. Overall CM, Kleifeld O (2006) Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br J Cancer 94(7):941-946. doi:10.1038/sj.bjc.6603043
155. PaalM, Heel T, Schneider R, Auer B (2009) A novel ecotin-ubiquitin-tag (ECUT) for efficient, soluble peptide production in the periplasm of Escherichia coli. Microb Cell Fact 8:7. doi:10.1186/1475-2859-8-7
156. Paetzel M, Dalbey RE, Strynadka NC (2000) The structure and mechanism of bacterial type I signal peptidases. A novel antibiotic target. Pharmacol Ther 87(1):27-49. doi:10.1016/S0163-7258(00)00064-4 (Pubitemid 30618986)
157. Page MJ, Di Cera E (2008) Evolution of peptidase diversity. J Biol Chem 283(44):30010-30014. doi:10.1074/jbc.M804650200
158. Park HS, Cleary PP (2005) Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils. Infect Immun 73 (12):7878-7886. doi:10.1128/IAI.73.12.7878-7886.2005
159. Payie KG,Weadge JT, Tanaka T, Yada RY (2000) Purification, N-terminal sequencing and partial characterization of a novel aspartic proteinase from the leaves of Medicago sativa L. (alfalfa). Biotechnol Lett 22 (19):1515-1520. doi:10.1023/a:1005656208075
160. Pereira IO, Assis DM, Juliano MA, Cunha RL, Barbieri CL, do Sacramento LV, Marques MJ, dos Santos MH (2011) Natural products from Garcinia brasiliensis as Leishmania protease inhibitors. J Med Food 14(6):557-562. doi:10.1089/jmf.2010.0018
161. Phylip LH, Lees WE, Brownsey BG, Bur D, Dunn BM, Winther JR, Gustchina A, Li M, Copeland T, Wlodawer A, Kay J (2001) The potency and specificity of the interaction between the IA3 inhibitor and its target aspartic proteinase from Saccharomyces cerevisiae. J Biol Chem 276(3):2023-2030. doi:10.1074/jbc. M008520200 (Pubitemid 32109682)
162. Polanowski A, Wilimowska-Pelc A, Kowalska J, Grybel J, Zelazko M, Wilusz T (2003)Non-conventional affinity chromatography of serine proteinases and their inhibitors. Acta Biochim Pol 50(3):765-773 (Pubitemid 38623808)
163. Potempa J, Pike RN (2009) Corruption of innate immunity by bacterial proteases. J Innate Immun 1(2):70-87. doi:10.1159/000181144
164. Potempa J, Pike R, Travis J (1997) Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (gingipains) using peptidyl chloromethanes. Biol Chem 378(3-4):223-230. doi:10.1515/bchm.1997.378. 3-4.223 (Pubitemid 27230607)
165. Potvin G, Ahmad A, Zhang Z (2010) Bioprocess engineering aspects of heterologous protein production in Pichia pastoris: a review. Biochemical Engineering Journal In Press, Corrected Proof. doi:10.1016/j.bej.2010.07.017
166. Quesada V, Ordonez GR, Sanchez LM, Puente XS, Lopez-Otin C (2009) The Degradome database: mammalian proteases and diseases of proteolysis. Nucleic Acids Res 37(Database issue): D239-D243
167. Rao MB, Tanksale AM, Ghatge MS, Deshpande VV (1998) Molecular and biotechnological aspects of microbial proteases. Microbiol Mol Biol Rev 62(3):597-635 (Pubitemid 28415546)
168. Rawlings ND (2010) Peptidase inhibitors in the MEROPS database. Biochimie. doi:10.1016/j.biochi.2010.04.013
169. Rawlings ND, Barrett AJ (2011) MEROPS: the peptidase database. Wellcome Trust. http://merops.sanger.ac.uk/. Accessed August 2011
170. Rawlings ND, Tolle DP, Barrett AJ (2004) Evolutionary families of peptidase inhibitors. Biochem J 378(Pt 3):705-716. doi:10.1042/BJ20031825 (Pubitemid 38406845)
171. Rawlings ND, Barrett AJ, Bateman A (2010) MEROPS: the peptidase database. Nucleic Acids Res 38(Database issue):D227-D233. doi:10.1093/nar/gkp971
172. Renko M, Sabotič J, Mihelič M, Brzin J, Kos J, Turk D (2010) Versatile loops in mycocypins inhibit three protease families. J Biol Chem 285(1):308-316. doi:10.1074/jbc.M109.043331
173. Renslo AR, McKerrow JH (2006) Drug discovery and development for neglected parasitic diseases. Nat Chem Biol 2(12):701-710. doi:10.1038/ nchembio837 (Pubitemid 44764212)
174. Rivard D, Anguenot R, Brunelle F, Le VQ, Vezina LP, Trepanier S, Michaud D (2006) An in-built proteinase inhibitor system for the protection of recombinant proteins recovered from transgenic plants. Plant Biotechnol J 4(3):359-368. doi:10.1111/j.1467-7652.2006.00187.x
175. Roberts TH, Hejgaard J, Saunders NF, Cavicchioli R, Curmi PM (2004) Serpins in unicellular eukarya, archaea, and bacteria: sequence analysis and evolution. J Mol Evol 59(4):437-447. doi:10.1007/s00239-004-2635-6 (Pubitemid 39305135)
176. Robinson MW, Dalton JP, Donnelly S (2008) Helminth pathogen cathepsin proteases: it's a family affair. Trends Biochem Sci 33 (12):601-608. doi:10.1016/j.tibs.2008.09.001
177. Rosenthal PJ (2003) Antimalarial drug discovery: old and new approaches. J Exp Biol 206(Pt 21):3735-3744. doi:10.1242/jeb.00589
178. Rozkov A, Enfors SO (2004) Analysis and control of proteolysis of recombinant proteins in Escherichia coli. Adv Biochem Eng Biotechnol 89:163-195. doi:10.1007/b95567
179. Ryan CA (1990) Protease inhibitors in plants - genes for improving defenses against insects and pathogens. Annu Rev Phytopathol 28:425-449. doi:10.1146/annurev.py.28.090190.002233
180. Sabotič J, Gaser D, Rogelj B, Gruden K, Štrukelj B, Brzin J (2006) Heterogeneity in the cysteine protease inhibitor clitocypin gene family. Biol Chem 387(12):1559-1566. doi:10.1515/BC.2006.194 (Pubitemid 44837580)
181. Sabotič J, Galeša K, Popovič T, Leonardi A, Brzin J (2007a) Comparison of natural and recombinant clitocypins, the fungal cysteine protease inhibitors. Protein Expr Purif 53(1):104-111. doi:10.1016/j.pep. 2006.11.015
182. Sabotič J, Trček T, Popovič T, Brzin J (2007b) Basidiomycetes harbour a hidden treasure of proteolytic diversity. J Biotechnol 128 (2):297-307. doi:10.1016/j.jbiotec.2006.10.006 (Pubitemid 46074196)
183. Sabotič J, Popovič T, Brzin J (2009a) Aspartic proteases from Basidiomycete Clitocybe nebularis. Croat Chem Acta 82(4):739-745
184. Sabotič J, Popovič T, Puizdar V, Brzin J (2009b) Macrocypins, a family of cysteine protease inhibitors from the basidiomycete Macrolepiota procera. FEBS J 276(16):4334-4345. doi:10.1111/j.1742-4658.2009. 07138.x
185. Sabotič J, Bleuler-Martinez S, Renko M, Avanzo Caglič P, Kallert S, Štrukelj B, Turk D, Aebi M, Kos J, Kunzler M (2012) Structural basis of trypsin inhibition and entomotoxicity of cospin, a serine protease inhibitor involved in defence of Coprinopsis cinerea fruiting bodies. J Biol Chem. doi:10.1074/jbc.M111.285304
186. Saegusa K, Ishimaru N, Yanagi K, Arakaki R, Ogawa K, Saito I, Katunuma N, Hayashi Y (2002) Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J Clin Invest 110 (3):361-369. doi:10.1172/JCI14682 (Pubitemid 34847968)
187. Salas CE, Gomes MTR, Hernandez M, Lopes MTP (2008) Plant cysteine proteinases: evaluation of the pharmacological activity. Phytochemistry 69(12):2263-2269. doi:10.1016/j.phytochem.2008.05.016
188. Santos CC, Scharfstein J, Lima AP (2006) Role of chagasin-like inhibitors as endogenous regulators of cysteine proteases in parasitic protozoa. Parasitol Res 99(4):323-324. doi:10.1007/s00436-006-0195-y (Pubitemid 44426718)
189. Schaller A (2004) A cut above the rest: the regulatory function of plant proteases. Planta 220(2):183-197. doi:10.1007/s00425-004-1407-2
190. Schirmeister T, Peric M (2000) Aziridinyl peptides as inhibitors of cysteine proteases: effect of a free carboxylic acid function on inhibition. Bioorg Med Chem 8(6):1281-1291. doi:10.1016/S0968-0896(00)00058-4 (Pubitemid 30398451)
191. Schluter U, Benchabane M, Munger A, Kiggundu A, Vorster J, Goulet MC, Cloutier C, Michaud D (2010) Recombinant protease inhibitors for herbivore pest control: a multitrophic perspective. J Exp Bot 61(15):4169-4183. doi:10.1093/jxb/erq166
192. Schmitt M, Janicke F, Graeff H (1992) Proteases, matrix degradation and tumor-cell spread. Churchill Livingstone
193. Segal BH (2006) Molecular pathogenesis of fungal infections. In: Runge MS, Patterson C (eds) Principles of molecular medicine. Humana Press, pp 920-933. doi:10.1007/978-1-59259-963-9-95
194. Sela MN (2001) Role of Treponema denticola in periodontal diseases. Crit Rev Oral Biol Med 12(5):399-413. doi:10.1177/10454411010120050301
195. Shabab M, Shindo T, Gu C, Kaschani F, Pansuriya T, Chintha R, Harzen A, Colby T, Kamoun S, van der Hoorn RA (2008) Fungal effector protein AVR2 targets diversifying defense-related cys proteases of tomato. Plant Cell 20(4):1169-1183. doi:10.1105/tpc.107.056325 (Pubitemid 352843986)
196. Sharma R, Katoch M, Srivastava P, Qazi G (2009) Approaches for refining heterologous protein production in filamentous fungi. World J Microbiol Biotechnol 25(12):2083-2094. doi:10.1007/s11274-009-0128-x
197. Shaw L, Golonka E, Potempa J, Foster SJ (2004) The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology 150(Pt 1):217-228. doi:10.1099/mic.0.26634-0 (Pubitemid 38111488)
198. Shoop WL, Xiong Y, Wiltsie J, Woods A, Guo J, Pivnichny JV, Felcetto T, Michael BF, Bansal A, Cummings RT, Cunningham BR, Friedlander AM, Douglas CM, Patel SB, Wisniewski D, Scapin G, Salowe SP, Zaller DM, Chapman KT, Scolnick EM, Schmatz DM, Bartizal K, MacCoss M, Hermes JD (2005) Anthrax lethal factor inhibition. Proc Natl Acad Sci U S A 102 (22):7958-7963. doi:10.1073/pnas. 0502159102 (Pubitemid 40781045)
199. Simoes I, Faro C (2004) Structure and function of plant aspartic proteinases. Eur J Biochem 271(11):2067-2075. doi:10.1111/j.1432-1033.2004. 04136.x (Pubitemid 38747976)
200. Sirois S, Zhang R, Gao WN, Gao H, Li Y, Zheng HQ, Wei DQ (2007) Discovery of potent anti-SARS-CoV M-Pro inhibitors. Curr Comput-Aid Drug 3(3):191-200. doi:10.1371/journal.pbio.0030324
201. Sottrup-Jensen L (1989) Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem 264 (20):11539-11542
202. Steenbakkers PJ, Irving JA, Harhangi HR, Swinkels WJ, Akhmanova A, Dijkerman R, Jetten MS, van der Drift C, Whisstock JC, Op den Camp HJ (2008) A serpin in the cellulosome of the anaerobic fungus Piromyces sp. strain E2. Mycol Res 112(Pt 8):999-1006. doi:10.1016/j.mycres.2008.01.021
203. Stepek G, Buttle DJ, Duce IR, Behnke JM (2006) Human gastrointestinal nematode infections: are new control methods required? Int J Exp Pathol 87(5):325-341. doi:10.1111/j.1365-2613.2006.00495.x (Pubitemid 44370913)
204. Stoeva S, Efferth T (2008) Human cytomegalovirus: drug resistance and new treatment options using natural products. Mol Med Rep 1 (6):781-785. doi:10.3892/Mmr-00000028
205. Sudarshana MR, Roy G, Falk BW (2007) Methods for engineering resistance to plant viruses. In: Ronald PM (ed) Plant-pathogen interactions: methods and protocols, vol 354. Methods in molecular biology. Humana Press Inc., pp 183-195. doi:10.1385/1592599664
206. Supuran CT, Scozzafava A, Clare BW (2002) Bacterial protease inhibitors. Med Res Rev 22(4):329-372. doi:10.1002/med.10007 (Pubitemid 34620472)
207. Suree N, JungME, Clubb RT (2007) Recent advances towards new antiinfective agents that inhibit cell surface protein anchoring in Staphylococcus aureus and other gram-positive pathogens. Mini Rev Med Chem 7(10):991-1000. doi:10.2174/138955707782110097 (Pubitemid 47554767)
208. Taguchi S, Kojima S, Terabe M, Kumazawa Y, Kohriyama H, Suzuki M, Miura K, Momose H (1997) Molecular phylogenetic characterization of Streptomyces protease inhibitor family. J Mol Evol 44(5):542-551. doi:10.1007/PL00006178 (Pubitemid 27227500)
209. Tahrani AA, Bailey CJ, Del Prato S, Barnett AH (2011) Management of type 2 diabetes: new and future developments in treatment. Lancet 378(9786):182-197. doi:10.1016/S0140-6736(11)60207-9
210. Terra WR, Ferreira C (1994) Insect digestive enzymes-properties, compartmentalization and function. Comp Biochem Phys B 109 (1):1-62. doi:10.1016/0305-0491(94)90141-4 (Pubitemid 24347628)
211. Tian M, Huitema E, Da Cunha L, Torto-Alalibo T, Kamoun S (2004) A Kazal-like extracellular serine protease inhibitor from Phytophthora infestans targets the tomato pathogenesis-related protease P69B. J Biol Chem 279(25):26370-26377. doi:10.1074/jbc.M400941200 (Pubitemid 38798788)
212. Tomlinson SM, Malmstrom RD, Watowich SJ (2009) New approaches to structure-based discovery of dengue protease inhibitors. Infect Disord Drug Targets 9(3):327-343
213. Travis J, Potempa J (2000) Bacterial proteinases as targets for the development of second-generation antibiotics. Biochim Biophys Acta 1477(1-2):35-50. doi:10.1016/S0167-4838(99)00278-2 (Pubitemid 30119890)
214. Trenholme KR, Brown CL, Skinner-Adams TS, Stack C, Lowther J, To J, Robinson MW, Donnelly SM, Dalton JP, Gardiner DL (2010) Aminopeptidases of malaria parasites: new targets for chemotherapy. Infect Disord Drug Targets 10(3):217-225. doi:10.2174/187152610791163363
215. Trinchese F, Fa M, Liu S, Zhang H, Hidalgo A, Schmidt SD, Yamaguchi H, Yoshii N,Mathews PM, Nixon RA, Arancio O (2008) Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. J Clin Invest 118(8):2796-2807. doi:10.1172/JCI34254
216. Tsuyuki H, Kajiwara K, Fujita A, Kumazaki T, Ishii S (1991) Purification and characterization of Streptomyces griseus metalloendopeptidases I and II. J Biochem 110(3):339-344
217. Turk B (2006) Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov 5(9):785-799. doi:10.1038/nrd2092
218. Turk BE (2008) Discovery and development of anthrax lethal factor metalloproteinase inhibitors. Curr Pharm Biotechnol 9(1):24-33. doi:10.2174/138920108783497604
219. Ulisse S, Baldini E, Sorrenti S, D'Armiento M (2009) The urokinase plasminogen activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets 9(1):32-71. doi:10.2174/156800909787314002
220. Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada M (1970) Pepstatin, a new pepsin inhibitor produced by actinomycetes. J Antibiot (Tokyo) 23(5):259-262
221. Vaccari M, Argnani A, Horn W, Silingardi P, Giungi M, Mascolo MG, Bartoli S, Grilli S, Colacci A (1999) Effects of the protease inhibitor antipain on cell malignant transformation. Anticancer Res 19(1A):589-596 (Pubitemid 29168298)
222. Valls Seron M, Haiko J, DEG PG, Korhonen TK, Meijers JC (2010) Thrombin-activatable fibrinolysis inhibitor is degraded by Salmonella enterica and Yersinia pestis. J Thromb Haemost 8 (10):2232-2240. doi:10.1111/j.1538-7836. 2010.04014.x
223. Valueva TA, Mosolov VV (2004) Role of inhibitors of proteolytic enzymes in plant defense against phytopathogenic microorganisms. Biochem Mosc 69(11):1305-1309. doi:10.1007/s10541-005-0015-5 (Pubitemid 40050049)
224. van der Hoorn RA (2008) Plant proteases: from phenotypes to molecular mechanisms. Annu Rev Plant Biol 59:191-223. doi:10.1146/annurev.arplant.59. 032607.092835
225. van Esse HP, Van't Klooster JW, Bolton MD, Yadeta KA, van Baarlen P, Boeren S, Vervoort J, de Wit PJ, Thomma BP (2008) The Cladosporium fulvum virulence protein Avr2 inhibits host proteases required for basal defense. Plant Cell 20(7):1948-1963. doi:10.1105/tpc.108.059394 (Pubitemid 352844543)
226. Vaseva I, Sabotič J, Šuštar-Vozlič J, Meglič V, Kidrič M, Demirevska K, Simova-Stoilova L (2012) The response of plants to drought stress - the role of dehydrins, chaperones, proteases and protease inhibitors in maintaining cellular protein function. In:NevesDF, Sanz JD (eds) Droughts: New Research. Nova Science Publishers, Inc.
227. Vathipadiekal V, Umasankar PK, Patole MS, Rao M (2010) Molecular cloning, over expression, and activity studies of a peptidic HIV-1 protease inhibitor: designed synthetic gene to functional recombinant peptide. Peptides 31(1):16-21. doi:10.1016/j.peptides.2009.09.034
228. Vincents B, von Pawel-Rammingen U, Bjorck L, Abrahamson M (2004) Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry 43(49):15540-15549. doi:10.1021/bi048284d (Pubitemid 39647479)
229. Vishnudasan D, Tripathi MN, Rao U, Khurana P (2005) Assessment of nematode resistance in wheat transgenic plants expressing potato proteinase inhibitor (PIN2) gene. Transgenic Res 14(5):665-675. doi:10.1007/s11248-005- 5696-4 (Pubitemid 41504317)
230. Volkov DA, Dergousova NI, Rumsh LD (2004) New aspartic proteinase of Ulysses retrotransposon from Drosophila virilis. Biochem Mosc 69(6):697-701. doi:10.1023/B:BIRY.0000033745.13652.9a
231. Walker AJ, Urwin PE, Atkinson HJ, Brain P, Glen DM, Shewry PR (1999) Transgenic Arabidopsis leaf tissue expressing a modified oryzacystatin shows resistance to the field slug Deroceras reticulatum (Muller). Transgenic Res 8(2):95-103. doi:10.1023/A:1008814317199 (Pubitemid 29368586)
232. Wang HM, Liang PH (2010) Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors. Expert Opin Ther Pat 20(1):59-71. doi:10.1517/13543770903460323
233. Wladyka B, Pustelny K (2008) Regulation of bacterial protease activity. Cell Mol Biol Lett 13(2):212-229. doi:10.2478/s11658-007-0048-4
234. Wong JH, Ng TB, Cheung RC, Ye XJ, Wang HX, Lam SK, Lin P, Chan YS, Fang EF, Ngai PH, Xia LX, Ye XY, Jiang Y, Liu F (2010) Proteins with antifungal properties and other medicinal applications from plants and mushrooms. Appl Microbiol Biotechnol 87(4):1221-1235. doi:10.1007/s00253-010-2690-4
235. Wu YR, Llewellyn D, Mathews A, Dennis ES (1997) Adaptation of Helicoverpa armigera (Lepidoptera: Noctuidae) to a proteinase inhibitor expressed in transgenic tobacco. Mol Breed 3(5):371- 380. doi:10.1023/A:1009681323131
236. Xu Y, Nakajima Y, Ito K, Zheng H, Oyama H, Heiser U, Hoffmann T, Gartner UT, Demuth HU, Yoshimoto T (2008) Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate- recognition mechanism. J Mol Biol 375 (3):708-719. doi:10.1016/j.jmb.2007.09.077 (Pubitemid 350297280)
237. Yao C (2010) Major surface protease of trypanosomatids: one size fits all? Infect Immun 78(1):22-31. doi:10.1128/IAI.00776-09
238. Yike I (2011) Fungal proteases and their pathophysiological effects. Mycopathologia 171(5):299-323. doi:10.1007/s11046-010-9386-2
239. Yun TH, Cott JE, Tapping RI, Slauch JM, Morrissey JH (2009) Proteolytic inactivation of tissue factor pathway inhibitor by bacterial omptins. Blood 113(5):1139-1148. doi:10.1182/blood-2008-05-157180
240. Zhang XX, Liu SK, Takano T (2008) Two cysteine proteinase inhibitors from Arabidopsis thaliana, AtCYSa and AtCYSb, increasing the salt, drought, oxidation and cold tolerance. Plant Mol Biol 68 (1-2):131-143. doi:10.1007/s11103-008-9357-x
241. Zucca M, Savoia D (2011) Current developments in the therapy of protozoan infections. Open Med Chem J 5:4-10. doi:10.2174/1874104501105010004